Spots Global Cancer Trial Database for dexamethasone acetate
Every month we try and update this database with for dexamethasone acetate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies | NCT01421173 | Lymphoma | Vorinostat Gemcitabine Busulfan Melphalan Stem Cell Infus... Rituximab G-CSF Palifermin Dexamethasone a... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00651261 | Leukemia | cytarabine daunorubicin midostaurin placebo dexamethasone a... | 18 Years - 59 Years | Alliance for Clinical Trials in Oncology | |
| Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) | NCT01868269 | Opsoclonus Myoc... Neuroblastoma | Dexamethasone a... dexamethasone a... dexamethasone a... | 6 Months - 8 Years | Institut Curie | |
| Dexamethasone for Pain Flare After Radiotherapy of Painful Bone metastasesZonMW 11510009 | NCT01669499 | Bone Metastases | Dexamethasone a... Placebo | 18 Years - | UMC Utrecht | |
| A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma | NCT01878708 | T-Cell Lymphoma Relapsed T-Cell... Refractory T-Ce... | PEG-L-asparagin... Dexamethasone a... | 18 Years - 65 Years | Dana-Farber Cancer Institute | |
| Dexamethasone for Pain Flare After Radiotherapy of Painful Bone metastasesZonMW 11510009 | NCT01669499 | Bone Metastases | Dexamethasone a... Placebo | 18 Years - | UMC Utrecht | |
| Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) | NCT01868269 | Opsoclonus Myoc... Neuroblastoma | Dexamethasone a... dexamethasone a... dexamethasone a... | 6 Months - 8 Years | Institut Curie | |
| Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old | NCT01916252 | Multiple Myelom... | bortezomib (Vel... lenalidomide (R... busulfan (Busil... Dexamethasone a... Melphalan | 18 Years - 65 Years | PETHEMA Foundation | |
| Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00651261 | Leukemia | cytarabine daunorubicin midostaurin placebo dexamethasone a... | 18 Years - 59 Years | Alliance for Clinical Trials in Oncology | |
| Effects of Steroid Tapering on Functional Capacity and Neurocognition | NCT01169415 | Glioblastoma Mu... | Dexamethasone a... Dexamethasone | 18 Years - 70 Years | Duke University | |
| Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) | NCT01868269 | Opsoclonus Myoc... Neuroblastoma | Dexamethasone a... dexamethasone a... dexamethasone a... | 6 Months - 8 Years | Institut Curie | |
| ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma | NCT01997840 | Multiple Myelom... | ACY-1215 (Ricol... | 18 Years - | Celgene | |
| Effects of Steroid Tapering on Functional Capacity and Neurocognition | NCT01169415 | Glioblastoma Mu... | Dexamethasone a... Dexamethasone | 18 Years - 70 Years | Duke University | |
| ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma | NCT01997840 | Multiple Myelom... | ACY-1215 (Ricol... | 18 Years - | Celgene | |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT02419469 | Leukemia Precursor-B Acu... Lymphoblastic L... Lymphoma | Cytarabine Daunorubicin Vincristine Prednisone PEG asparaginas... Ofatumumab Rituximab Methotrexate Cyclophosphamid... Mercaptopurine Doxorubicin Dexamethasone a... Thioguanine | 12 Years - 30 Years | M.D. Anderson Cancer Center | |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT02419469 | Leukemia Precursor-B Acu... Lymphoblastic L... Lymphoma | Cytarabine Daunorubicin Vincristine Prednisone PEG asparaginas... Ofatumumab Rituximab Methotrexate Cyclophosphamid... Mercaptopurine Doxorubicin Dexamethasone a... Thioguanine | 12 Years - 30 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
